Skip to main content
Equibles

NOMURA HOLDINGS INC

Position in GILD — Gilead Sciences, Inc.

CIK 1163653 TOKYO, M0
Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,509,043
-$3,028,897 QoQ
Shares Held
154,417
-4.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#325
of 2,265 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2026
CallValue
$1,895,100
CallShares
15,000
PutValue
$1,895,100
PutShares
15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NOMURA HOLDINGS INC holds $312,301,632 across 14 Drug Manufacturers - General names. GILD ranks #6 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 58,931 $70,683,614
2 JNJ
Johnson & Johnson
 242,836 $61,673,057
3 ABBV
AbbVie Inc.
 109,358 $27,518,846
4 MRK
Merck & Co., Inc.
 198,276 $25,478,465
5 AMGN
Amgen Inc
 69,010 $24,989,900
6 GILD
Gilead Sciences, Inc.
This page 		154,417 $19,509,043
7 AZN
Astrazeneca PLC
 95,936 $18,191,384
8 PFE
Pfizer Inc
 632,863 $15,239,339

All Filings in GILD

Export CSV
47 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,509,043 154,417
2026-06-30 $1,895,100 15,000
2026-06-30 $1,895,100 15,000
2026-03-31 $22,537,940 161,713
2026-03-31 $9,755,900 70,000
2025-12-31 $12,531,754 102,100
2025-12-31 $31,431,994 256,086
2025-12-31 $3,939,954 32,100
2025-09-30 $11,333,100 102,100
2025-09-30 $34,659,972 312,252
2025-09-30 $3,563,100 32,100
2025-06-30 $17,357,917 156,561
2025-06-30 $22,362,479 201,700
2025-06-30 $11,530,480 104,000
2025-03-31 $24,326,055 217,100
2025-03-31 $18,492,283 165,036
2025-03-31 $10,319,805 92,100
2024-12-31 $2,771,100 30,000
2024-12-31 $461,850 5,000
2024-12-31 $26,188,187 283,514
2024-09-30 $19,290,074 230,082
2024-09-30 $2,515,200 30,000
2024-06-30 $8,744,618 127,454
2024-06-30 $7,204,050 105,000
2024-03-31 $2,197,500 30,000
2024-03-31 $2,393,589 32,677
2023-12-31 $1,490,827 18,403
2023-12-31 $2,430,300 30,000
2023-12-31 $2,276,381 28,100
2023-09-30 $1,701,138 22,700
2023-09-30 $661,120 8,822
2023-06-30 $878,443 11,398
2023-03-31 $3,733,650 45,000
2023-03-31 $1,506,735 18,160
2022-12-31 $41,293 481
2022-12-31 $81,978,165 954,900
2022-06-30 $561,295 9,081
2022-06-30 $43,267,000 700,000
2022-03-31 $2,743,913 46,155
2021-12-31 $17,799,324 245,136
2021-09-30 $7,229,404 103,499
2021-06-30 $4,832,662 70,181
2021-03-31 $784,608 12,140
2020-12-31 $5,475,099 93,977
2020-09-30 $3,294,410 52,135
2020-06-30 $223,202 2,901
2020-03-31 $747,600 10,000

Report a Problem

Category
Description
Email (optional, for follow-up)